latest news on tirzepatide FDA says the weight-loss drug shortage is over Eli Lilly drug tirzepatide meets
Description
It's worth noting that GLP-1 receptor agonists are not recommended in patients with severe gastrointestinal disease, such as severe gastroparesis, as stated in the SmPC
Furthermore, many studies are based on small participant numbers or short study periods
If a clinically significant hypersensitivity reaction occurs, institute appropriate therapy and discontinue DUPIXENT
A few things to consider
While the capsules are easy to take and I didnt encounter any major side effects, I havent seen the improvements I was hoping for
